Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhi gancao Decoction (also known as Zhigancao Tang or Roasted Licorice Decoction) is a classic Traditional Chinese Medicine (TCM) formula first documented in the *Shanghan Lun* (Treatise on Febrile Diseases). It is primarily indicated for the treatment of cardiovascular conditions characterized by palpitations and an irregular or intermittent pulse, traditionally attributed to Yin and Yang deficiency and Qi and Blood insufficiency. The formula is composed of nine ingredients: honey-fried licorice (the sovereign herb), cinnamon twig, fresh ginger, ginseng, rehmannia root, ophiopogon tuber, hemp seed, donkey-hide gelatin, and jujube. In modern clinical research, it is frequently evaluated for its efficacy in treating arrhythmias, such as paroxysmal atrial fibrillation, particularly when used as an adjunctive therapy to Western medications like metoprolol. Its pharmacological effects are thought to involve the modulation of cardiac ion channels and the improvement of myocardial energy metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zhi gancao Decoction.